ARCALYST trademark registration was filed on December 19, 2011, and the mark was successfully registered with the EUIPO on April 9, 2014 under EUTM trademark no. 010505097.
Regeneron Pharmaceuticals, Inc., who is the trademark holder was represented by J A KEMP (EUIPO registered representative, ID no. 10662).
Across the opposition process there was 1 opposition raised. It was filed by BIOFARMA, société par actions simplifiée on April 23, 2012. GEVERS FRANCE was the opponent's representative.
Expiration date for the current trademark registration is December 19, 2021.
|Trademark Name||ARCALYST||Trademark No.||010505097|
|Filling Date||December 19, 2011||Registration Date||April 9, 2014|
|Reference||TM26871JAF/CS||Status Date||April 11, 2014|
|Owner||Regeneron Pharmaceuticals, Inc.|
|Legal Status||Legal entity|
|Address||Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
|Representative||J A KEMP|
|Legal Status||Legal person|
|Address||J A KEMP
14 South Square
London WC1R 5JJ
Pharmaceutical, Veterinary Products, Dietetic
Pharmaceutical and medicinal preparations provided in injectable form for the regulation of immune and inflammatory responses, all of which must be stored refrigerated.
Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.